Monounsaturated fatty acid-enriched diet decreases plasma plasminogen activator inhibitor type 1

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 1, 1996, Pages 82-88

  Lopez Segura, F ^a   Velasco, F ^a   Lopez Miranda, J ^a   Castro, P ^a   Lopez Pedrera, R ^a   Blanco, A ^a   Jimenez Pereperez, J ^a   Torres, A ^a   Trujillo, J ^a   Ordovas, J M ^b   Pérez Jiménez, Francisco ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b TUFTS UNIVERSITY   (United States)

Author keywords

fibrinolytic system; insulin; low fat diets; monounsaturated fatty acid rich diets; plasminogen activator inhibitor type 1

Indexed keywords

CARBOHYDRATE; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOTTING; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; DISEASE ASSOCIATION; FAT INTAKE; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; LOW FAT DIET; MALE; NORMAL HUMAN; PATHOGENESIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 9044247067     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.1.82     Document Type: Article

References (57)

1. Thompson WD, Smith EB. Atherosclerosis and the coagulation system. J Pathol. 1989;159:97-106.
2. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250, 310-318.
3. Naito M, Funaki C, Hayashi T, Yamada K, Asai K, Yoshimine N, Kuzuya F. Substrate-bound fibrinogen, fibrin and other cell attachment-promoting proteins as a scaffold for cultured vascular smooth muscle cells. Atherosclerosis. 1992;96:227-234.
4. Smith EB, Cochram S. Factors influencing the accumulation in fibrous plaque of lipid derived from low density lipoprotein, II: preferential immobilization of lipoprotein (a). Atherosclerosis. 1990;84:173-181.
5. Juhan-Vague I, Alessi MC. Plasminogen activator inhibitor 1 and atherothrombosis. Thromb Haemost. 1993;70:138-143.
6. Hamsten A, De Faire Y, Walldius G, Dahlen G, Szamosi A, Landou C, Blomback M, Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 1987;2:3-9.
7. Ridker PM, Vaugham DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet. 1993;341:1165-1168.
8. Thompson SG, Van De Loo JCW. ECAT Angina Pectoris Study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Eur Heart J. 1993;14:8-17.
9. Vague P, Juhan-Vague I, Aillaud MF, Badier C, Viard R, Alessi MC, Collen D. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and relative body weight in normal and obese subjects. Metabolism. 1986;35:250-253.
10. Juhan-Vague I, Vague P, Alessi MC, Badier C, Valadier J, Aillaud MF, Atlan C. Relationships between plasma insulin, triglyceride, body mass index and plasminogen activator inhibitor 1. Diabete Metab. 1987;13:331-336.
11. Juhan-Vague I, Alessi MC, Joly P, Thirion X, Vague P, Declerck PJ, Serradimigni A, Collen D. Plasma plasminogen activator inhibitor in angina pectoris: influence of plasma insulin and acute-phase response. Arteriosclerosis. 1989;9:362-367.
12. Thompson SG, Kienast J, Pyke S, Haverkate F, Van de Loo J. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635-641.
13. Nordoy A, Goodnight SH. Dietary lipids and thrombosis: relationships to atherosclerosis. Arteriosclerosis. 1990;10:149-163.
14. Shekelle RB, Shryock AN, Paul O, Lepe H, Stamler J, Liu S, Raynor WJ. Diet, serum cholesterol and death from coronary heart disease. N Engl J Med. 1981;304:65-70.
15. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials. Arterioscler Thromb. 1992;12:911-919.
16. Emeis JJ, Van Houwelingen AC, Van Den Hoogen CM, Hornstra G. A moderate fish intake increases plasminogen activator inhibitor type-1 in human volunteers. Blood. 1989;74:233-237.
17. Berg-Schmidt E, Varming K, Ernst E, Madsen P, Dyerberg J. Doseresponse studies on the effect of n-3 polyunsaturated fatty acids on lipids and haemostasis. Thromb Haemost. 1990;63:1-5.
18. Fumeron F, Brigant L, Ollivier V, De Prost D, Driss F, Darcet P, Bard JM, Parra HJ, Fruchart JC, Apfelbaum M. n-3 Polyunsaturated fatty acids raise low-density lipoproteins, high-density lipoprotein 2, and plasminogen-activator inhibitor in healthy young men. Am J Clin Nutr, 1991;54:118-122.
19. Marckmann P, Sandström B, Jespersen J. Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arterioscler Thromb. 1993;13:505-511.
20. Heinrich J, Wahrburg U, Martin H, Assmann G. The effect of diets, rich in mono- or polyunsaturated fatty acids on lipid metabolism and haemostasis. Fibrinolysis. 1990;4(suppl 1):76-78.
21. Padró T, Emeis JJ, Beynen AC. Effect of amount and type of dietary fat on plasma fibrinolytic components in rats. Nutr Metab Cardiovasc Dis. 1993;3:10-16.
22. The Adult Treatment Panel. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
23. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1975;17:237-246.
24. Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrombin complex in plasma with an enzyme linked immunosorbent assay. Thromb Haemost. 1988;59:101-106.
25. Pelzer H, Schwart A, Stuber W. Determination of human prothrombin activation of fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemost. 1991;65:153-159.
26. Friberger P, Knos M, Justavsson S, Aurell L, Claeson G. Methods for the determination of plasmin, antiplasmin and plasminogen by means of the substrate S-2251. Haemostasis. 1978;7:138-145.
27. Teger-Nilsson AC, Friberger P, Gyzander E. Determination of a new rapid plasma inhibitor in human blood by means of a plasmin specific tripeptide substrate. Scand J Clin Lab Invest. 1977;37:403-404.
28. Amiral J, Adalbert B, Adam M. Application of enzyme immunoassay to coagulation testing. Clin Chem. 1984;30:1512-1517.
29. Declerck PJ, Alessi MC, Vertreken M, Kmithof EKO, Juhan-Vague I, Collen D. Measurement of plasminogen activator 1 in biological fluid with a marine monoclonal antibody based enzyme-linked immunosorbent assay. Blood. 1988;71:220-225.
30. Chmielewska J, Ranby M, Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res. 1983;31:427-436.
31. Ziola BR, Matikainen MT, Salmi A. Polystyrene balls as the solid phase of a double antibody radioimmunoassay for human serum albumin. J Immunol Methods. 1977;15:309-317.
32. Terpstra AH, Woodward CJ, Sanchez-Muniz FJ. Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation: visualization by prestaining and rapid separation of serum lipoproteins from small volumes of serum. Anal Biochem. 1981;111:149-157.
33. Bucolo G, David H. Quantitative determination of serum triglycerides by use of enzymes. Clin Chem. 1973;19:476-482.
34. Allain CC, Poon LS, Chang CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-475.
35. Riepponen P, Marniemi J, Rautaoja T. Immunoturbidimetric determination of apolipoproteins A-1 and B in serum. Scand J Clin Lab Invest. 1987;47:739-744.
36. Ruiz-Gutierrez V, Prada JL, Pérez-Jimenez F. Determination of fatty acid and triacylglycerol composition of human very-lowdensity lipoproteins. J Chromatogr. 1993;622:117-124.
37. Schneiderman J, Sawdey MS, Keeton MR, Bordin GM, Bernstein EF, Dilley RB, Luskutoff DJ. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA. 1992;89:6998-7002.
38. Marckmann P, Sandström B, Jespersen J. Dietary effects on circadian fluctuation in human blood coagulation factor VII and fibrinolysis. Atherosclerosis. 1993;101:225-234.
39. Silveira A, Karpe F, Blombäck M, Steiner G, Walldius G, Hamsten A. Activation of coagulation factor VII during alimentary lipemia. Arterioscler Thromb. 1994;14:60-69.
40. Salomaa V, Rasi V, Pekkanen J, Jauhiainen M, Vahtera E, Pietinen P, Korhonen H, Kuulasmaa K, Ehnholm C. The effects of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and hemostatic activity. Atherosclerosis. 1993;103:1-11.
41. Bladbjerg EM, Marckmann P, Sandström B, Jespersen J. Nonfasting factor VII coagulant activity (FVII:C) increased by high-fat diet. Thromb Haemost. 1994;71:755-758.
42. Marckmann P, Sandström B, Jespersen J. Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids. Atherosclerosis. 1990;80:227-233.
43. Mitropoulos KA, Miller GJ, Martin JC, Reeves BEA, Cooper J. Dietary fat induces changes in factor VII coagulant activity through effects on plasma free stearic acid concentration. Arterioscler Thromb. 1994;14:214-222.
44. Brace LD, Gittler-Buffa C, Miller GJ, Cole TG, Schmeisser D. Prewitt TE, Bowen PE. Factor VII coagulant activity and cholesterol changes in premenopausal women consuming a long-term cholesterol-lowering diet. Arterioscler Thromb. 1994;14:1284-1289.
45. Marckmann P, Jespersen J, Leth T, Sandström B. Effect of fish diet versus meat diet on blood lipids, coagulation and fibrinolysis in healthy young men. J Intern Med. 1991;229:317-323.
46. Froschl H, Spannagl M, Drummer C, Landgraf-Leurs MMC, Eangraf R, Schramm W. Effect of cicosapentaenoic acid diet on humoral clotting and fibrinolysis parameters in type-1 diabetes mellitus. Haemostasis. 1988;18(suppl 2):27-28.
47. Perez-Jimenez F, Espino A, Eopez-Segura F, Blanco J, Ruiz-Gutierrez V, Prada JL, Lopez-Miranda J, Jimenez-Pereperez J, Ordovas JM. Lipoprotein concentrations in normolipemic males consuming oleic acid rich diets from two different sources: olive oil and oleic-rich sunflower oil. Am J Clin Nutr. 1995;62:769-775.
48. Quax PHA, Van den Hoogen CM, Verheijen JH, Padró T, Zeheb R, Gelehrter TD, Van Berkel TJ, Kuiper J, Emeis JJ. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vitro. J Biol Chem. 1990;265:15560-15563.
49. Fujii S, Lucore CL, Hopkins WE, Billadello JJ, Sobel BE. Induction of synthesis of plasminogen activator inhibitor type 1 by tissue-type plasminogen activator in human hepatic and endothelial cells. Thromb Haemost. 1990;64:412-419.
50. Emeis JJ, Van den Hoogen CM. Pharmacological modulation of the endotoxin-induced increase in plasminogen activator inhibitor activity in rats. Blood Coagul Fibrinolysis. 1992;3:575-581.
51. Stiko-Rahm A, Wiman B, Hamsten A, Nilsson J. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical endothelial cells is induced by very low density lipoprotein. Arteriosclerosis. 1990;10:1067-1073.
52. Hegsted DM, McGandy RB, Myers ML, Stare FJ. Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr. 1965;17:281-295.
53. Juhan-Vague I, Roul C. Alessi MC, Ardissone JP, Heim M, Vague P. Increased plasminogen activator inhibitor activity in non-insulin dependent diabetic patients: relationship with plasma insulin. Thromb Haemost. 1989;61:370-373.
54. Juhan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor 1 levels: a possible link between insulin resistance and atherothrombosis. Diabetologia. 1991;34:457-462.
55. Schneider DJ, Nordt TK, Sobel BE. Stimulation by proinsulin of expression of plasminogen activator inhibitor type 1 in endothelial cells. Diabetes. 1992;41:890-895.
56. Alessi MC, Juhan-Vague I, Kooistra T, Declerck PJ, Collen D. Insulin stimulates the synthesis of plasminogen activator inhibitor by the human hepatocellular cell line Hep G2. Thromb Haemost. 1988;60:491-494.
57. Fatal PC, Schneider DJ, Sobel BE, Billadello JJ. Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1. J Biol Chem. 1992;267:12412-12415.